Association of IgM type anti-GM1 antibodies and muscle strength in chronic acquired demyelinating polyneuropathy

Annals of Neurology

Volumn 43, Issue 1, 1998, Pages 72-78

  Bech, Einar ^a   Andersen, Henning ^a   Ørntoft, Torben F ^a   Jakobsen, Johannes ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE GM1; IMMUNOGLOBULIN M;

ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; DEMYELINATING NEUROPATHY; DISEASE ACTIVITY; DYNAMOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MUSCLE STRENGTH; PRIORITY JOURNAL;

ADULT; ANTIBODIES; CHRONIC DISEASE; DEMYELINATING DISEASES; FEMALE; G(M1) GANGLIOSIDE; HUMANS; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; MUSCLES; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 0031890231     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410430113     Document Type: Article

References (26)

1. van Schaik IN, Bossuyt PM, Brand A, Vermeulen M. Diagnostic value of GM1 antibodies in motor neuron disorders and neuropathies: a meta-analysis. Neurology 1995;45:1570-1577
2. Sadiq SA, Thomas FP, Kilidireas K, et al. The spectrum of neurologic disease associated with anti-GM1 antibodies. Neurology 1990;40:1067-1072
3. Feldman EL, Bromberg MB, Albers JW, Pestronk A. Immunosuppressive treatment in multifocal motor neuropathy. Ann Neurol 1991;30:397-401
4. Taylor BV, Gross L, Windebank AJ. The sensitivity and specificity of anti-GM1 antibody testing. Neurology 1996;47:951-955
5. Schwerer B, Lassmann H, Kitz K, Bernheimer H. Ganglioside GM1, a molecular target for immunological and toxic attacks: similarity of neuropathological lesions induced by ganglioside-antiserum and cholera toxin. Acta Neuropathol Berl 1986;72: 55-61
6. Thomas FP, Trojaborg W, Nagy C, et al. Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier. Acta Neuropathol Berl 1991;82:378-383
7. Roberts M, Willison HJ, Vincent A, Newsom-Davis J. Multifocal motor neuropathy human sera block distal motor nerve conduction in mice. Ann Neurol 1995;38:111-118
8. Marcus DM, Latov N, Hsi BP, Gillard BK. Measurement and significance of antibodies against GM1 ganglioside (Report of a workshop). J Neuroimmunol 1989;25:255-259
9. van Schaik IN, Vermeulen M, van Doorn PA, Brand A. Anti-GM1 antibodies in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) treated with intravenous immunoglobulin (IVIg). J Neuroimmunol 1994;54:109-115
10. Chaudhry V, Corse AM, Cornblath DR, et al. Multifocal motor neuropathy: response to human immune globulin. Ann Neurol 1993;33:237-242
11. Malik U, Oleksowicz L, Latov N, Cardo LJ. Intravenous gamma-globulin inhibits binding of anti-GM1 to its target antigen. Ann Neurol 1996;39:136-139
12. Bech E, Jakobsen J, Orntoft TF. ELISA-type titertray assay of IgM anti-GM1 autoantibodies. Clin Chem 1994;40:1331-1334
13. Bech E, Orntoft TF, Andersen LP, et al. IgM antibodies in the Guillain-Barré syndrome: a serological predictor of the clinical course. J Neuroimmunol 1997;72:59-66
14. Andersen H. Reliability of isokinetic measurements of ankle dorsal and plantar flexors in normal subjects and in patients with peripheral neuropathy. Arch Phys Med Rehabil 1996;77: 265-268
15. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Neurology 1991;41:617-618
16. Lewis RA, Sumner AJ, Brown MJ, Asbury AK. Multifocal demyelinating neuropathy with persistent conduction block. Neurology 1982;32:958-964
17. Medical Research Council. Aids to the examination of the peripheral nervous system. Memorandum No. 45. London: Her Majesty's Stationary Office, 1976
18. Parry GJ. Antiganglioside antibodies do not necessarily play a role in multifocal motor neuropathy. Muscle Nerve 1994;17: 97-99
19. Lange DJ, Trojaborg W. Do GM1 antibodies induce demyelination? Muscle Nerve 1994;17:105-107
20. Schwartz M, Sela BA, Eshhar N. Antibodies to gangliosides and myelin autoantigens are produced in mice following sciatic nerve injury. J Neurochem 1982;38:1192-1195
21. Corbo M, Quattrini A, Latov N, Hays AP. Localization of GM1 and Gal(beta 1-3)GalNAc antigenic determinants in peripheral nerve. Neurology 1993;43:809-814
22. Schluep M, Steck AJ. Immunostaining of motor nerve terminals by IgM M protein with activity against gangliosides GM1 and GD1b from a patient with motor neuron disease. Neurology 1988;38:1890-1892
23. Uncini A, Santoro M, Corbo M, et al. Conduction abnormalities induced by sera of patients with multifocal motor neuropathy and anti-GM1 antibodies. Muscle Nerve 1993;16:610-615
24. Arasaki K, Kusunoki S, Kudo N, Kanazawa I. Acute conduction block in vitro following exposure to antiganglioside sera. Muscle Nerve 1993;16:587-593
25. + currents in isolated rat myelinated nerve fibers. Ann Neurol 1995;37:436-442
26. Santoro M, Thomas FP, Fink ME, et al. IgM deposits at nodes of Ranvier in a patient with amyotrophic lateral sclerosis, anti-GM1 antibodies, and multifocal motor conduction block. Ann Neurol 1990;28:373-377